Intellipharmaceutics International Company Profile (NASDAQ:IPCI)

About Intellipharmaceutics International

Intellipharmaceutics International logoIntellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The Company's Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. It has developed several drug delivery systems and a pipeline of products and product candidates in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The Hypermatrix family of technologies includes IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliPellets, IntelliShuttle, Point of Divergence Drug Delivery System (nPODDDS) and Paradoxical OverDose Resistance Activating System (PODRAS). Its products include Focalin XR, Keppra XR, Effexor XR, Protonix, Seroquel XR, Lamictal XR, Pristiq, Oleptro, Coreg CR, OxyContin and Lyrica.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IPCI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.81
  • 50 Day Moving Average: $1.74
  • 200 Day Moving Average: $1.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 4.53
  • P/E Growth: 0.00
  • Market Cap: $52.03M
  • Outstanding Shares: 28,747,000
  • Beta: 0.8
Additional Links:
Companies Related to Intellipharmaceutics International:

Analyst Ratings

Consensus Ratings for Intellipharmaceutics International (NASDAQ:IPCI) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.67 (378.82% upside)

Analysts' Ratings History for Intellipharmaceutics International (NASDAQ:IPCI)
Show:
DateFirmActionRatingPrice TargetDetails
7/22/2016Maxim GroupReiterated RatingBuyView Rating Details
7/5/2016Brean CapitalReiterated RatingBuy$8.00View Rating Details
10/13/2015MackieSet Price TargetBuy$12.00View Rating Details
2/24/2015NomuraDowngradeNeutralView Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Intellipharmaceutics International (NASDAQ:IPCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/13/2016Q216($0.09)($0.08)$1.30 millionViewN/AView Earnings Details
10/9/2015Q315($0.04)($0.08)ViewN/AView Earnings Details
7/13/2015Q215($0.05)($0.06)$1.20 millionViewN/AView Earnings Details
4/14/2015($0.08)($0.04)ViewN/AView Earnings Details
2/23/2015($0.07)($0.06)ViewN/AView Earnings Details
10/15/2014Q3($0.05)($0.07)ViewN/AView Earnings Details
4/14/2014Q114$0.11$0.09$4.49 million$4.70 millionViewN/AView Earnings Details
2/18/2014($0.08)($0.31)ViewN/AView Earnings Details
4/3/2013Q113($0.12)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intellipharmaceutics International (NASDAQ:IPCI)
Current Year EPS Consensus Estimate: $-0.28 EPS
Next Year EPS Consensus Estimate: $0.40 EPS

Dividends

Dividend History for Intellipharmaceutics International (NASDAQ:IPCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intellipharmaceutics International (NASDAQ:IPCI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Intellipharmaceutics International (NASDAQ:IPCI)
DateHeadline
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Company In Focus: Analysts & Crowd Weigh in - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - August 25 at 5:43 PM
stockhouse.com logoIntellipharmaceutics International Inc T.I (NASDAQ:IPCI)
www.stockhouse.com - August 24 at 5:32 PM
News IconConsensus Weighing in on Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Post News (NASDAQ:IPCI)
www.kentuckypostnews.com - August 19 at 5:40 PM
investornewswire.com logoWill Intellipharmaceutics International Inc. (NASDAQ:IPCI) Hit $8 Price Target? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - August 19 at 5:40 PM
News IconAdaptive Ad Systems, Inc. (OTC Pink: AATV), 400% Growth Over 2016 Projected $9 Million Revenue, $3.2 Million Net Profit (NASDAQ:IPCI)
ih.advfn.com - August 18 at 8:42 AM
investornewswire.com logoCan Shares Of Intellipharmaceutics International Inc. (NASDAQ:IPCI) Hit $8? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 30 at 8:35 AM
investornewswire.com logoIs $8 Price Target Attainable For Intellipharmaceutics International Inc. (NASDAQ:IPCI)? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 22 at 5:35 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - TGP (NASDAQ:IPCI)
telanaganapress.com - July 21 at 5:50 PM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:IPCI)
www.engelwooddaily.com - July 20 at 8:43 AM
News IconTrading Performance and Target Watch for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Press Telegraph (NASDAQ:IPCI)
presstelegraph.com - July 18 at 10:54 AM
investornewswire.com logoStrong Sell Calls For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 0 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 16 at 9:02 AM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:IPCI)
www.engelwooddaily.com - July 13 at 8:34 AM
News IconAnalyst Target and Average Rating Watch: Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Press Telegraph (NASDAQ:IPCI)
presstelegraph.com - July 13 at 8:34 AM
investornewswire.com logoIs $12 Within Reach For Intellipharmaceutics International Inc. (NASDAQ:IPCI)? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 10 at 10:00 AM
fiscalstandard.com logoBroker Outlook For Intellipharmaceutics International Inc. (IPCI) - Fiscal Standard (NASDAQ:IPCI)
www.fiscalstandard.com - July 8 at 8:33 AM
ftsenews.co.uk logoNew Broker Ratings For Intellipharmaceutics International Inc. (IPCI) - FTSE News (NASDAQ:IPCI)
www.ftsenews.co.uk - July 6 at 5:53 PM
investornewswire.com logoIntellipharmaceutics International Inc. (NASDAQ:IPCI) Expected to Reach Highs Of $12 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - July 3 at 10:03 AM
ftsenews.co.uk logoIntellipharmaceutics International Inc. (IPCI) Updated Price Targets - FTSE News (NASDAQ:IPCI)
www.ftsenews.co.uk - June 29 at 5:36 PM
investornewswire.com logoEarnings Surprise in Focus: Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 29 at 5:36 PM
kcregister.com logoInvestors Alert: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), PrivateBancorp, Inc. (NASDAQ:PVTB), Bristol ... - KC Register (NASDAQ:IPCI)
www.kcregister.com - June 29 at 8:30 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Intellipharmaceutics International Inc. (IPCI) - Fiscal Standard (NASDAQ:IPCI)
www.fiscalstandard.com - June 27 at 10:00 AM
investornewswire.com logoStrong Sell Calls Recommendations For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 0 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 26 at 5:03 PM
investornewswire.com logoCan Intellipharmaceutics International Inc. (NASDAQ:IPCI) Surprise Analysts this Quarter? - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 19 at 9:50 AM
investornewswire.com logoStrong Buy Calls Count For Intellipharmaceutics International Inc. (NASDAQ:IPCI) At 2 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - June 19 at 9:50 AM
finance.yahoo.com logoIntellipharmaceutics Closes Public Offering for US$5.2 Million (NASDAQ:IPCI)
finance.yahoo.com - June 6 at 5:30 PM
kcregister.com logoOncoSec Medical Incorporated (NASDAQ:ONCS) went up 5.56%: IntelliPharmaCeutics International Inc. (NASDAQ ... - KC Register (NASDAQ:IPCI)
www.kcregister.com - May 31 at 10:01 AM
kcregister.com logoIntelliPharmaCeutics International (NASDAQ:IPCI) went down -1.86%: Transocean Ltd. (NYSE:RIG), NVIDIA (NASDAQ ... - KC Register (NASDAQ:IPCI)
www.kcregister.com - May 31 at 10:01 AM
News IconStock Review and Earnings Check on Intellipharmaceutics International Inc. (NASDAQ:IPCI) - HNN (NASDAQ:IPCI)
hintsnewsnetwork.com - May 31 at 10:01 AM
streetupdates.com logoSummary of Price Movements: Seattle Genetics, Inc. (NASDAQ:SGEN) , Intellipharmaceutics International Inc ... - Street Updates (NASDAQ:IPCI)
www.streetupdates.com - May 31 at 10:01 AM
News IconNext Weeks Broker Price Targets For Intellipharmaceutics International Inc. (IPCI) - Share Trading News (NASDAQ:IPCI)
www.sharetrading.news - May 30 at 10:52 PM
realistinvestor.com logoAnalysts Set 1-Year Price Target Of $8.666 On Intellipharmaceutics International Inc. (NASDAQ:IPCI) Stock - RealistInvestor.com (NASDAQ:IPCI)
www.realistinvestor.com - May 27 at 8:33 PM
publicnow.com logoIntellipharmaceutics Announces Pricing of $5.2 Million Public Offering of Common Shares and Warrants (NASDAQ:IPCI)
www.publicnow.com - May 27 at 9:57 AM
News IconStock Reaching a Recent Low: IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) - Wall Street Hints and News (NASDAQ:IPCI)
hintsnewsnetwork.com - May 26 at 8:21 PM
publicnow.com logoIntellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants (NASDAQ:IPCI)
www.publicnow.com - May 26 at 5:47 PM
finance.yahoo.com logo5:26 pm Intellipharmaceutics Intl files to offer units of common shares and warrants in an underwritten public offering (NASDAQ:IPCI)
finance.yahoo.com - May 26 at 5:26 PM
News IconEarnings Review and Stock Rundown for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - Wall Street Hints and News (NASDAQ:IPCI)
hintsnewsnetwork.com - May 24 at 8:13 PM
stocksdaily.net logoIntellipharmaceutics International Inc. (NASDAQ:IPCI) Comprehensive Income At $0.2844 For Period Ended 2015-11-30 - Stocks Daily (NASDAQ:IPCI)
www.stocksdaily.net - May 13 at 8:25 PM
News IconDialing Back Euphoria: The Intellipharmaceutics Prescription for Opioid Abuse (NASDAQ:IPCI)
jutiagroup.com - May 12 at 2:08 AM
News IconConsensus Rating Review for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - B.O.D.Y Confidential (NASDAQ:IPCI)
www.bodyconfidential.com - May 11 at 8:49 PM
News IconAverage Analyst Rating for Intellipharmaceutics International Inc. (NASDAQ:IPCI) - B.O.D.Y Confidential (NASDAQ:IPCI)
www.bodyconfidential.com - May 4 at 8:26 PM
stocksdaily.net logoIntellipharmaceutics International Inc. (NASDAQ:IPCI) EBITDA Yearly Stands At $-6.7356 Millions - Stocks Daily (NASDAQ:IPCI)
www.stocksdaily.net - April 29 at 8:53 PM
News IconCurrent Price Targets For Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers (NASDAQ:IPCI)
www.risersandfallers.com - April 28 at 2:38 AM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Share Rating Recap - B.O.D.Y Confidential (NASDAQ:IPCI)
www.bodyconfidential.com - April 27 at 3:32 AM
News IconAnalyst Coverage: Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers (NASDAQ:IPCI)
www.risersandfallers.com - April 26 at 8:22 PM
investornewswire.com logoIntellipharmaceutics International Inc. (NASDAQ:IPCI) Reported Basic Consolidated EPS Of $-0.3129 - Investor Newswire (NASDAQ:IPCI)
www.investornewswire.com - April 23 at 8:11 PM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Analyst Rating Review - B.O.D.Y Confidential (NASDAQ:IPCI)
www.bodyconfidential.com - April 22 at 10:21 PM
News IconRecently Changed Price Targets On Intellipharmaceutics International Inc. (IPCI) - Risers & Fallers (NASDAQ:IPCI)
www.risersandfallers.com - April 22 at 10:21 PM
News IconBroker Outlook For Intellipharmaceutics International Inc. (IPCI) - Share Trading News (NASDAQ:IPCI)
www.sharetrading.news - April 21 at 10:07 PM
News IconIntellipharmaceutics International Inc. (NASDAQ:IPCI) Share Rating Recap - The Post (NASDAQ:IPCI)
www.bibeypost.com - April 21 at 10:07 PM
finance.yahoo.com logoINTELLIPHARMACEUTICS INTERNATIONAL INC. Financials (NASDAQ:IPCI)
finance.yahoo.com - March 24 at 1:04 PM

Social

Intellipharmaceutics International (NASDAQ:IPCI) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff